ロード中...
Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
As of 28 October 2020, there are over 44 000 000 confirmed COVID-19 infections and over 1 000 000 deaths worldwide, including 945 367 infections and 45 765 deaths in the UK. Acute respiratory distress syndrome occurs in 50% of patients with secondary haemophagocytic lymphohistiocytosis, a hyperinfla...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7798428/ https://ncbi.nlm.nih.gov/pubmed/33419750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-238210 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|